KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Dividends Paid - Common (2016 - 2025)

Thermo Fisher Scientific's Dividends Paid - Common history spans 14 years, with the latest figure at $162.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Dividends Paid - Common rose 8.72% year-over-year to $162.0 million, compared with a TTM value of $636.0 million through Dec 2025, up 9.09%, and an annual FY2025 reading of $636.0 million, up 9.09% over the prior year.
  • Dividends Paid - Common for Q4 2025 was $162.0 million at Thermo Fisher Scientific, down from $163.0 million in the prior quarter.
  • The five-year high for Dividends Paid - Common was $163.0 million in Q3 2025, with the low at $87.0 million in Q2 2021.
  • Average Dividends Paid - Common over 5 years is $129.6 million, with a median of $135.0 million recorded in 2023.
  • Year-over-year, Dividends Paid - Common increased 18.39% in 2021 and then rose 8.67% in 2025.
  • Tracing TMO's Dividends Paid - Common over 5 years: stood at $103.0 million in 2021, then grew by 13.59% to $117.0 million in 2022, then increased by 16.24% to $136.0 million in 2023, then increased by 9.56% to $149.0 million in 2024, then increased by 8.72% to $162.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Dividends Paid - Common are $162.0 million (Q4 2025), $163.0 million (Q3 2025), and $162.0 million (Q2 2025).